Trastuzumab-based therapy is effective for salivary duct carcinoma: Case report and review of the literature

Oral Oncol. 2019 Apr:91:121-122. doi: 10.1016/j.oraloncology.2019.02.015. Epub 2019 Mar 1.

Authors

Shihai Wu¹, Rencui Quan², Ling Han³

Affiliations

¹ Department of Radiation Oncology, Second Clinical Medicine College of Jinan University, Shenzhen People's Hospital, China. Electronic address: [email protected].
² Department of Radiation Oncology, Second Clinical Medicine College of Jinan University, Shenzhen People's Hospital, China.
³ Department of Otorhinolaryngology, Second Clinical Medicine College of Jinan University, Shenzhen People's Hospital, China.

PMID: 30827840
DOI: 10.1016/j.oraloncology.2019.02.015

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Antineoplastic Agents, Immunological / pharmacology
Antineoplastic Agents, Immunological / therapeutic use
Humans
Male
Middle Aged
Salivary Gland Neoplasms / drug therapy*
Trastuzumab / pharmacology
Trastuzumab / therapeutic use

Substances

Antineoplastic Agents, Immunological
Trastuzumab